Deloitte March 30, 2021

Perspectives

How pharma and medtech can shift from doing digital to being digital

Digital transformation is no longer a buzzword—it’s a strategic imperative. Life Science companies should tackle enterprise-wide digital transformation head-on with a holistic, business-driven approach.

Digital transformation: A new competitive imperative

A convergence of events— COVID-19, the acceleration of digital health, economic uncertainty, ecosystem collaboration, and new competition—has impacted life sciences by both accelerating and advancing digital initiatives already underway, and it has jump-started future initiatives. Companies that understand the impact of these events also understand that to thrive, they should change the way they approach digital transformation.

In an...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Health IT, Pharma / Biotech, Technology
High cost of weight loss drugs drives employers to require nutrition counseling, in boost for startups
Announcement: Andreessen Horowitz Partners with Lilly to Launch First-of-Its-Kind Biotech Ecosystem Fund
Boosting biopharma R&D performance with a next-generation technology stack
Charting the path to patients
External innovation: Biopharma dealmaking to boost R&D productivity

Share This Article